Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4724 ARTÍCULOS , VIENDO DEL 1291 AL 1305

Cholesterol-Recognition Motifs in Membrane Proteins

Fantini J, Epand RM, Barrantes FJ.

Adv Exp Med Biol. 2019;1135:3-25. doi: 10.1007/978-3-030-14265-0_1.

Current status and potential role of circular RNAs in neurological disorders

Lu S, Yang X, Wang C, Chen S, Lu S, Yan W, Xiong K, Liu F, Yan J.

J Neurochem. 2019 Aug;150(3):237-248. doi: 10.1111/jnc.14724. Epub 2019 Jun 6.

Effects of alpha-synuclein post-translational modifications on metal binding

González N, Arcos-López T, König A, Quintanar L, Menacho Márquez M, Outeiro TF, Fernández CO.

J Neurochem. 2019 Sep;150(5):507-521. doi: 10.1111/jnc.14721. Epub 2019 Jul 9.

[The Major Human Stress Protein Hsp70 as a Factor of Protein Homeostasis and a Cytokine-Like Regulator]

Garbuz DG, Zatsepina OG, Evgen'ev MB.

Mol Biol (Mosk). 2019 Mar-Apr;53(2):200-217. doi: 10.1134/S0026898419020058.

Circulating messenger for neuroprotection induced by molecular hydrogen

Noda M, Uemura Y, Yoshii Y, Horita T, Takemi S, Sakata I, Sakai T.

Can J Physiol Pharmacol. 2019 Oct;97(10):909-915. doi: 10.1139/cjpp-2019-0098. Epub 2019 May 17.

Comparing the effects of progressive and mild intensity treadmill running protocols on neuroprotection of parkinsonian rats

Fallah Mohammadi Z, Falah Mohammadi H, Patel DI.

Life Sci. 2019 Jul 15;229:219-224. doi: 10.1016/j.lfs.2019.05.036. Epub 2019 May 14.

Dyskinesia-Hyperpyrexia Syndrome in Parkinson's disease with Deep Brain Stimulation and high-dose levodopa/carbidopa and entacapone

Novelli A, Di Vico IA, Terenzi F, Sorbi S, Ramat S.

Parkinsonism Relat Disord. 2019 Jul;64:352-353. doi: 10.1016/j.parkreldis.2019.05.018. Epub 2019 May 11.

Heterogeneity in progression of prodromal features in Parkinson's disease

Schrag A, Zhelev SS, Hotham S, Merritt RD, Khan K, Graham L.

Parkinsonism Relat Disord. 2019 Jul;64:275-279. doi: 10.1016/j.parkreldis.2019.05.013. Epub 2019 May 10.

Dopamine dysregulation syndrome induced by proxy

Reis Carneiro D, Sousa M, Morgadinho A, Januário C.

BMJ Case Rep. 2019 May 16;12(5):e228495. doi: 10.1136/bcr-2018-228495.

Neuronal Mitophagy: Lessons from a Pathway Linked to Parkinson's Disease

Corti O.

Neurotox Res. 2019 Aug;36(2):292-305. doi: 10.1007/s12640-019-00060-8. Epub 2019 May 17.

Structure-dependent activation of gene expression by bis-indole and quinoline-derived activators of nuclear receptor 4A2

Li X, Tjalkens RB, Shrestha R, Safe S.

Chem Biol Drug Des. 2019 Oct;94(4):1711-1720. doi: 10.1111/cbdd.13564. Epub 2019 Jul 21.

Toxoplasma gondii infection and risk of Parkinson and Alzheimer diseases: A systematic review and meta-analysis on observational studies

Bayani M, Riahi SM, Bazrafshan N, Ray Gamble H, Rostami A.

Acta Trop. 2019 Aug;196:165-171. doi: 10.1016/j.actatropica.2019.05.015. Epub 2019 May 15.

The current status of pharmacotherapy for the treatment of Parkinson's disease: transition from single-target to multitarget therapy

Cheong SL, Federico S, Spalluto G, Klotz KN, Pastorin G.

Drug Discov Today. 2019 Sep;24(9):1769-1783. doi: 10.1016/j.drudis.2019.05.003. Epub 2019 May 16.

Nocebo response in Parkinson's disease: A systematic review and meta-analysis

Leal Rato M, Duarte GS, Ferreira AN, Alves M, Mainoli B, Teodoro T, Mestre TA, Costa J, Ferreira JJ.

Parkinsonism Relat Disord. 2019 Aug;65:13-19. doi: 10.1016/j.parkreldis.2019.04.015. Epub 2019 Apr 20.

Parkinson's disease and long-term exposure to outdoor air pollution: A matched case-control study in the Netherlands

Toro R, Downward GS, van der Mark M, Brouwer M, Huss A, Peters S, Hoek G, Nijssen P, Mulleners WM, Sas A, van Laar T, Kromhout H, Vermeulen R.

Environ Int. 2019 Aug;129:28-34. doi: 10.1016/j.envint.2019.04.069. Epub 2019 May 16.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias